Ticker Scorecard - ANIP Basics Company: ANI Pharmaceuticals, Inc. IPO Date: July 18, 2013 Sector: Healthcare Industry: Pharma Market Cap: $1.21B Activated in VL: True Average Daily Range Avg Daily Range: $0.90 | 2.07% Avg Daily Range (30 D): $0.66 | 1.13% Avg Daily Range (90 D): $0.77 | 1.33% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .12M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 40 Avg Trade Size (Sh.) (90 D): 41 Institutional Trades Total Inst.Trades: 1,803 Avg Inst. Trade: $1.73M Avg Inst. Trade (30 D): $2.13M Avg Inst. Trade (90 D): $2.24M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.97M Avg Closing Trade (30 D): $2.23M Avg Closing Trade (90 D): $2.4M Avg Closing Volume: 35.53K     News Oct 30, 2024 @ 9:00 PM ANI Pharmaceuticals to Discuss Third Quarter 2024 ... Source: N/A Oct 18, 2024 @ 6:38 PM Avadel Obtains FDA Nod for Label Expansion Of Narc... Source: Zacks Oct 17, 2024 @ 5:44 PM Alnylam Stock Up on Cardiomyopathy Drug Regulatory... Source: Zacks Sep 24, 2024 @ 7:08 PM BHVN Stock Up as Rare Neurological Disease Study M... Source: Zacks Sep 16, 2024 @ 12:53 PM ANI Pharmaceuticals, Inc. Completes Acquisition of... Source: Globe Newswire Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.47 $-1.27 $-.14 Diluted EPS $-.47 $-1.27 $-.14 Revenue $ 555.46M $ 148.33M $ 138.04M Gross Profit $ $ $ Net Income / Loss $ -7.09M $ -24.17M $ -2.29M Operating Income / Loss $ 11.69M $ -20.52M $ 5.17M Cost of Revenue $ $ $ Net Cash Flow $ -48.06M $ -95.09M $ 11.51M PE Ratio     Splits Jul 18, 2013:   6:1 Jun 04, 2012:   6:1 Jun 03, 2002:   10:1